About MPS Pharmaa Ltd 
MPS Pharmaa Ltd
Small Cap
Pharmaceuticals & Biotechnology
Advik Laboratories Ltd has been set up from the ground level with the avowed objective of achieving USFDA standards of quality. The product range includes ethical i.e. Wibatol, Wibatol-O, Robial, Twosum, Majispa, Arfa Gel, Stibomin and Chewfe-C., generic drugs i.e. antibacterials, antiallergics, antifungals, analgesic, antipyretic and anti-inflammatory, anti-hypertensives, anthelminthics, anti-malarials, corticosteroids, erectile dysfunction, gastrointestinal agents and sedatives. and over the counter drugs (OTC) in various formulations.
Company Coordinates 
Company Details
138 Roz-Ka-Meo Industrial Area, Sohna Mewat Haryana : 122103
Registrar Details
MAS Services Ltd, T-34 , 2nd Floor, Okhla Industrial Area, Phase - II, New Delhi
Capital Structure 
Present Equity Capital
INR 19.11 Cr
Number of Shares
1.91 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
15-May-2015
1.91
19.11
4082650
10
Conversion of Warrants
15-May-2015
1.91
19.11
4082650
10
Conversion of Warrants
21-Nov-2013
1.5
15.03
5675350
10
Conversion of Warrants
21-Nov-2013
1.5
15.03
5675350
10
Conversion of Warrants
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Non Institution
Pledged Promoter Holdings
16.0362
Mutual Funds
Held by 0 Schemes
FIIs
Held by 0 FIIs
Promoter with highest holding
Omkam Pharmaceuticals Private Limited (25.65%)
Highest Public shareholder
Pataliputra International Limited (17.51%)
Individual Investors Holdings
37.07%
Management
Designation
Remuneration
Peeyush Kumar Aggarwal
Managing Director
0
Manoj Kumar Jain
Independent Director
0
Pooja Chuni
Company Secretary
2.91 lacs
Madhu Sharma
Independent Director
0
Ram Niwas Sharma
Director
0
Raw Materials Dashboard 
Raw Materials
Amount(Rs Cr)
% of RM Cost
Active Raw Materials
212540000
0%
Active Raw Materials
Finished Goods Dashboard 
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Other Operating Revenue - Income from Jobwork
0.10
2.34%
Other Operating Revenue - Income from Jobwork
Other Operating Revenue - Income from Jobwork
Revenue and Profits:
Net Sales:
(Quarterly Results - Jun 2025)
Net Profit:
0 Cr
Pharmaceuticals & Biotechnology
INR 4 Cr (Small Cap)
NA (Loss Making)
30
0.00%
6.90
-83.28%
3.68






